Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005;1(4):291-9.
doi: 10.2147/vhrm.2005.1.4.291.

Cardiovascular consequences of cortisol excess

Affiliations
Review

Cardiovascular consequences of cortisol excess

Judith A Whitworth et al. Vasc Health Risk Manag. 2005.

Abstract

Cushing's syndrome is a consequence of primary or, more commonly, secondary oversecretion of cortisol. Cardiovascular disease is the major cause of morbidity and mortality in Cushing's syndrome, and excess risk remains even in effectively treated patients. The cardiovascular consequences of cortisol excess are protean and include, inter alia, elevation of blood pressure, truncal obesity, hyperinsulinemia, hyperglycemia, insulin resistance, and dyslipidemia. This review analyses the relationship of cortisol excess, both locally and at tissue level, to these cardiovascular risk factors, and to putative mechanisms for hypertension. Previous studies have examined correlations between cortisol, blood pressure, and other parameters in the general population and in Cushing's syndrome. This review also details changes induced by short-term cortisol administration in normotensive healthy men.

PubMed Disclaimer

Comment in

  • Corticosteroids and endothelial dysfunction.
    Tabrizchi R. Tabrizchi R. Vasc Health Risk Manag. 2005;1(4):261-2. doi: 10.2147/vhrm.2005.1.4.261. Vasc Health Risk Manag. 2005. PMID: 17315598 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Agrest A, Finkielman S, Elijovich F. Hemodynamics of arterial hypertension in Cushing's syndrome. Medicina (B Aires) 1974;34:457–62. - PubMed
    1. Andrews RC, Herlihy O, Livingstone DE, et al. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab. 2002;87:5587–93. - PubMed
    1. Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci. 1999;96:513–23. - PubMed
    1. Berger J, Tanen M, Elbrecht A, et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem. 2001;276:12629–35. - PubMed
    1. Bjorntorp P, Rosmond R. Obesity and cortisol. Nutrition. 2000;16:924–36. - PubMed

MeSH terms